Lepeltier E - Search Results

1

Microbiota and cancer: In vitro and in vivo models to evaluate nanomedicines.

Ladaycia A, Loretz B, Passirani C, Lehr CM, Lepeltier E. Ladaycia A, et al. Among authors: lepeltier e. Adv Drug Deliv Rev. 2021 Mar;170:44-70. doi: 10.1016/j.addr.2020.12.015. Epub 2020 Dec 31. Adv Drug Deliv Rev. 2021. PMID: 33388279 Free article. Review.

2

Microbiota and nanoparticles: Description and interactions.

Ladaycia A, Passirani C, Lepeltier E. Ladaycia A, et al. Among authors: lepeltier e. Eur J Pharm Biopharm. 2021 Dec;169:220-240. doi: 10.1016/j.ejpb.2021.10.015. Epub 2021 Nov 1. Eur J Pharm Biopharm. 2021. PMID: 34736984 Review.

3

Squalenoylation of Chitosan: A Platform for Drug Delivery?

Lepeltier E, Loretz B, Desmaële D, Zapp J, Herrmann J, Couvreur P, Lehr CM. Lepeltier E, et al. Biomacromolecules. 2015 Sep 14;16(9):2930-9. doi: 10.1021/acs.biomac.5b00840. Epub 2015 Aug 6. Biomacromolecules. 2015. PMID: 26221873

4

Nanomedicine to target multidrug resistant tumors.

Lepeltier E, Rijo P, Rizzolio F, Popovtzer R, Petrikaite V, Assaraf YG, Passirani C. Lepeltier E, et al. Drug Resist Updat. 2020 Sep;52:100704. doi: 10.1016/j.drup.2020.100704. Epub 2020 May 25. Drug Resist Updat. 2020. PMID: 32512316 Review.

5

Ferrocifen stealth LNCs and conventional chemotherapy: A promising combination against multidrug-resistant ovarian adenocarcinoma.

Idlas P, Ladaycia A, Némati F, Lepeltier E, Pigeon P, Jaouen G, Decaudin D, Passirani C. Idlas P, et al. Among authors: lepeltier e. Int J Pharm. 2022 Oct 15;626:122164. doi: 10.1016/j.ijpharm.2022.122164. Epub 2022 Sep 8. Int J Pharm. 2022. PMID: 36089209

6

Nanomedicine as a potent strategy in melanoma tumor microenvironment.

Pautu V, Leonetti D, Lepeltier E, Clere N, Passirani C. Pautu V, et al. Among authors: lepeltier e. Pharmacol Res. 2017 Dec;126:31-53. doi: 10.1016/j.phrs.2017.02.014. Epub 2017 Feb 20. Pharmacol Res. 2017. PMID: 28223185 Review.

7

Not just for tumor targeting: unmet medical needs and opportunities for nanomedicine.

Lepeltier EA, Nuhn L, Lehr CM, Zentel R. Lepeltier EA, et al. Nanomedicine (Lond). 2015;10(20):3147-66. doi: 10.2217/nnm.15.132. Epub 2015 Oct 8. Nanomedicine (Lond). 2015. PMID: 26447353 Review.

8

Design of Polyamine-Grafted Starches for Nucleotide Analogue Delivery: In Vitro Evaluation of the Anticancer Activity.

Kanber E, Yamada H, Loretz B, Lepeltier E, Lehr CM. Kanber E, et al. Among authors: lepeltier e. Bioconjug Chem. 2016 Oct 19;27(10):2431-2440. doi: 10.1021/acs.bioconjchem.6b00396. Epub 2016 Oct 3. Bioconjug Chem. 2016. PMID: 27633934

9

Multidisciplinary Preclinical Investigations on Three Oxamniquine Analogues as New Drug Candidates for Schistosomiasis*.

Buchter V, Ong YC, Mouvet F, Ladaycia A, Lepeltier E, Rothlisberger U, Keiser J, Gasser G. Buchter V, et al. Among authors: lepeltier e. Chemistry. 2020 Nov 26;26(66):15232-15241. doi: 10.1002/chem.202002856. Epub 2020 Oct 22. Chemistry. 2020. PMID: 32852116

10

Ferrocifen Loaded Lipid Nanocapsules: A Promising Anticancer Medication against Multidrug Resistant Tumors.

Idlas P, Lepeltier E, Jaouen G, Passirani C. Idlas P, et al. Among authors: lepeltier e. Cancers (Basel). 2021 May 11;13(10):2291. doi: 10.3390/cancers13102291. Cancers (Basel). 2021. PMID: 34064748 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

39 results

Search Page